Navigation Links
SyntheMed Receives Brazilian Regulatory Approval for REPEL-CV(TM)
Date:9/9/2009

re. It is designed to perform the therapeutic task and then degrade so that it is cleared from the body.

About SyntheMed, Inc.

SyntheMed, Inc. is a biomaterials company engaged in the development and commercialization of anti-adhesion products based on its proprietary bioresorbable polymer technology.

Statements in this Press Release that are not statements of historical fact, constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements involve known and unknown risks, uncertainties and other factors which may cause the actual results, performance or achievements of the company, or industry results, to be materially different from any future results, performance, or achievements expressed or implied by such forward-looking statements. Such risks and uncertainties include but are not limited to (i) potential adverse developments regarding the company's efforts to obtain and maintain FDA and other required regulatory approvals; (ii) potential inability to secure funding as and when needed to support the company's future activities and (iii) unanticipated delays associated with manufacturing and marketing activities. Reference is made to the company's Annual Report on Form 10-KSB for the year ended December 31, 2008 for a description of these, as well as other, risks and uncertainties.


'/>"/>
SOURCE SyntheMed, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. SyntheMed Receives Russian Regulatory Approval for REPEL-CV(TM)
2. SyntheMed Receives US Patent on Novel Polymer Technology
3. SyntheMed Receives Frost & Sullivan Health Innovation Award Nomination
4. SyntheMed Receives Australian Regulatory Approval for REPEL-CV(R)
5. FDA Approves SyntheMeds REPEL-CV(R) Adhesion Barrier for Use in Pediatric Cardiac Surgery
6. SyntheMed Announces FDA Clearance of SinusShield(TM)
7. SyntheMed Announces New Management Appointments
8. SyntheMed Completes $4.0 Million Equity Placement
9. SyntheMed To Present at the AdvaMed 2008 MedTech Conference
10. SyntheMed to Present at Canaccord Adams Small-Cap Orthopedics Conference
11. SyntheMed Files Universal Shelf Registration
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... of Engineering at the University of Delaware, is ... in energy engineering, environmental sustainability and electronics. , ... rock with a well-defined, crystalline structure. At the ... decided that zeolites can separate molecules with size ... (one-tenth of a nanometer), making them useful to ...
(Date:7/24/2014)... , July 24, 2014 SRI International ... with the National Institute of Allergy and Infectious Diseases ... conduct preclinical development of potential therapies for HIV infection ... to treat HIV and AIDS and the complications and ... microbicides for preventing sexual transmission of HIV. ...
(Date:7/24/2014)... 24, 2014 WIRB-Copernicus Group ® ... ethical review services for clinical research, announced today ... division of Richmond, VA -based ... and biosecurity consulting firm in the ... biosafety division – WCG Biosafety™ – will be ...
(Date:7/24/2014)... DIEGO , July 24, 2014   ... announced today the appointment of Adam Simpson ... Cypher Genomics provides rapid and comprehensive annotation and ... and clinical reporting. "Cypher,s technology has ... improve healthcare by enhancing diagnostic accuracy, optimizing therapeutic ...
Breaking Biology Technology:University of Delaware researcher describes new approach for creating organic zeolites 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 2National Institute of Allergy and Infectious Diseases Awards SRI International Contract to Study New Therapies for HIV and AIDS 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 2Cypher Genomics Announces the Appointment of Adam Simpson as President and COO to Advance Transformative Genome Interpretation Technology 3
... , , , ... Inc. (Nasdaq: ITMN ) today announced that it will ... help further the research of inherited genetic factors that may play ... researchers at National Jewish with access to DNA collected from patients ...
... ... announced that Henry "Pete" Linsert, Jr. has joined its Board of Directors. , ... Alachua, FL (PRWEB) September ... joined its Board of Directors., , ,Mr. Linsert is President and CEO of Columbia ...
... BETHESDA, Md., Sept. 16 American Capital Ltd. ... 15, it completed the sale of its portfolio company Axygen ... Inc., to Corning Incorporated for approximately $400 million. The ... fee income, from the equity invested by American Capital,s affiliated ...
Cached Biology Technology:InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis 2InterMune Announces Collaboration With National Jewish Health on NIH-Supported Genetic Research in Idiopathic Pulmonary Fibrosis 3NovaMin Technology Inc. Welcomes New Board Member 2American Capital Receives $182 Million In Proceeds From Sale of Axygen Bioscience 2American Capital Receives $182 Million In Proceeds From Sale of Axygen Bioscience 3American Capital Receives $182 Million In Proceeds From Sale of Axygen Bioscience 4
(Date:7/24/2014)... led by the University of York has carried out ... Western Indian Ocean. , The results, reported in ... revolution in the management of marine protected areas, with ... km in the region now under local community ... the seas and coasts designed to protect wildlife from ...
(Date:7/24/2014)... scientists from Singapore have developed Asia,s first genetic test ... that affects the cornea called corneal stromal dystrophy which ... , Called the POLARIS TGFBI (Transforming Growth Factor beta ... in the diagnosis and management of patients with corneal ... a TGFBI mutation who may also be at risk ...
(Date:7/23/2014)... A new study of identical twins has found that ... The study, in the journal Child Development , ... and King,s College London. , "Since reading is an ... for reading instruction," according to Stuart J. Ritchie, research ... led the study. "Early remediation of reading problems might ...
Breaking Biology News(10 mins):Western Indian Ocean communities play vital role in conservation 2Singapore team develops Asia's first genetic test that can prevent corneal blindness 2Singapore team develops Asia's first genetic test that can prevent corneal blindness 3Stronger early reading skills predict higher intelligence later 2
... a perceived danger, is a response that differs from ... scientists thought. Now researchers at Tel Aviv University are ... has implications for helping clinicians better treat victims of ... and his graduate student Rony Izhar of Tel Aviv ...
... biologists at the University of Toronto (U of T) ... determining whether a species opts for sexual over asexual ... Becks and Professor Aneil Agrawal of the Department of ... spatially heterogenous environments habitats characterized by uneven concentrations ...
... BEDFORD, Mass., Oct. 14 Aware, Inc. (Nasdaq: ... telecommunications and biometrics industries, has scheduled a conference call to ... on Thursday, October 28, 2010, at 5:00 p.m. Eastern Time. ... host the earnings conference call. This call is ...
Cached Biology News:Is anxiety contagious? 2Is anxiety contagious? 3Aware, Inc. Announces Q3'10 Earnings Conference Call 2
Request Info...
Detect and measure levels of mouse IgG2b antibody isotypes quickly and easily....
Detect and measure levels of mouse IgG3 antibody isotypes quickly and easily....
ExonBio Service provides one-stop recobinant protein shopping from cloning, expression and purification. Price including gene cloning....
Biology Products: